Human dental pulp cells (HDPCs) were isolated from freshly extracted third molar and cultured. The over-expression of PPAR纬 was used by adenoviral PPAR纬 (Ad/PPAR纬). The formation of ROS was analysed using DCFH-DA with FACS, and NO was analysed using colorimetric bioassay. The expression of inflammatory molecules and inflammatory mechanism of PPAR纬 involved signal pathway were determined by immunoblotting.
LPS-induced HDPC decreased PPAR纬 expression gradually and strongly activated the ERK1/2 signals amongst the MAPK, and induced NF-魏B translocation from the cytosol to the nucleus. On the other hand, the cells to restore PPAR纬 with Ad/PPAR纬 were inhibited ERK1/2 despite being stimulated with LPS. In addition, the cells treated with rosiglitazone (PPAR纬 agonist) also were inhibited ERK1/2 activation, and the expression of ICAM-1, VCAM-1 and NF-魏B translocation under LPS stimulation. The GW9667 (PPAR纬 antagonist)-treated HDPC did not affect the adhesion molecules and signal activation. LPS-induced HDPC produced significant NO and ROS levels, but their production was attenuated in the PPAR纬 over-expressed cells. Overall, the PPAR纬 effect under LPS stimulation is due to the removal activity of cellular NO and ROS formation.
These results suggest that anti-inflammatory mechanism of PPAR纬 is due to the removal activity of NO and ROS, and its removal effect suppressed ERK1/2 signal activation and NF-魏B translocation. Therefore, the NO and ROS removal activity of PPAR纬 suggests major anti-inflammatory mechanism in HDPC, and it might offer us a possible molecule for various types of inflammatory inhibition.